Juanita Mora, MD
Allergy & Immunology · Chicago, ILNPI 1750557179
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 44.7% of the total. Among allergy & immunology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,045 payments — averaging $140.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$66K
- GSK$52K
- AstraZeneca$10K
- Sanofi$7K
- Regeneron Healthcare Solutions, Inc.$3K
- Novartis$2K
- plus $7K from 28 others
What the payments were for
- Consulting fees$75,08851%
- Speaking & faculty fees$40,74528%
- Travel & lodging$7,8145%
- Food & beverage$22,93116%
- Education$570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 161 | $65,501 |
| GSK | 93 | $51,921 |
| AstraZeneca | 147 | $10,435 |
| Sanofi | 104 | $7,084 |
| Regeneron Healthcare Solutions, Inc. | 102 | $2,678 |
| Novartis | 107 | $1,858 |
| CSL Behring | 59 | $1,453 |
| Biocryst US Sales Co., LLC | 29 | $624 |
| Genentech USA, Inc. | 30 | $607 |
| Greer Laboratories, Inc. | 26 | $522 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $512 |
| Optinose US, Inc. | 35 | $500 |
| ARS Pharmaceuticals Operations, Inc. | 22 | $471 |
| Pharming Healthcare, Inc. | 19 | $378 |
| Amgen(2 entities) | 14 | $333 |
| Kaleo, Inc. | 14 | $291 |
| Alk-abello, Inc | 6 | $197 |
| Phadia US Inc. | 10 | $160 |
| Ionis Pharmaceuticals, Inc. | 5 | $148 |
| Pfizer | 8 | $142 |
| Blueprint Medicines Corporation | 1 | $112 |
| LEO Pharma Inc. | 6 | $101 |
| Shire North American Group Inc | 4 | $94 |
| Octapharma USA, Inc. | 2 | $86 |
| Cycle Pharmaceuticals Inc | 2 | $63 |
| Galderma Laboratories, L.p. | 4 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $62 |
| Genentech, Inc. | 2 | $54 |
| Biocryst Pharmaceuticals, Inc. | 2 | $52 |
| Grifols USA, LLC | 2 | $48 |
| Merck | 2 | $31 |
| Hospira, Inc. | 2 | $22 |
| USWM, LLC | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CINQAIR$46,969
- ProAir Digihaler$11,400
- AirDuo RespiClick$10,400
- ArmonAir Digihaler$10,400
- AREXVY$10,400
- AUSTEDO$3,398
- DUPIXENT$2,706
- XOLAIR$359
- FASENRA$269
- NEFFY$142
- COSENTYX$134
- AYVAKIT$112
How this compares
$146,635 in reported general payments places this provider in the 95th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TezspireTezepelumab-Ekko | 14 | $57,055 |
| XolairOmalizumab | 17 | $43,198 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $13,282 |
| Fluticasone Propionate | 169 | $2,558 |
| Montelukast Sodium | 205 | $1,752 |
| Ventolin HfaAlbuterol Sulfate | 25 | $1,460 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,145 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $887 |
| Hydroxyzine Hcl | 57 | $537 |
| Prednisone | 188 | $507 |
| Levocetirizine Dihydrochloride | 22 | $235 |
| Triamcinolone Acetonide | 29 | $228 |
| Doxepin Hcl | 11 | $208 |
| Azithromycin | 67 | $175 |
| Levofloxacin | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire | $10,435 | $57,05514 claims |
| Genentech, Inc.Xolair | $54 | $43,19817 claims |
| GSKTrelegy Ellipta | $51,921 | $13,28217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 161 allergy & immunology providers in Illinois.
Other allergy & immunology in Chicago
- Anju PetersChicago$563K
- Giselle MosnaimChicago$331K
- Amanda SalihChicago$160K
- Christina CiaccioChicago$73K
- Michael FoggsChicago$71K
- Melanie MakhijaChicago$56K
- Whitney StevensChicago$34K
- Andrea Pappalardo WlochowiczChicago$33K
- Krishan ChhibaChicago$23K
- Sharmilee NyenhuisChicago$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.